Opendata, web and dolomites

IMPACT SIGNED

Improving DNA Analysis for Correct Healthcare

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IMPACT project word cloud

Explore the words cloud of the IMPACT project. It provides you a very rough idea of what is the project "IMPACT" about.

subsequent    molecular    installing    chamber    microfluidics    engaged    put    capital    brings    financing    xdrop    2019    operate    plan    multibillion    strategy    razor    trade    place    samplix    bulk    blade    diagnosis    subscription    opposed    estate    total    team    revolutionized    healthcare    providers    single    drug    launch    gt    despite    droplet    revenue    tumour    droplets    full    agreements    raised    scientists    sequencing    profitability    families    instrument    retrieve    return    encompasses    freedom    core    patent    bioinformatics    oem    immunological    selling    biological    medical    commercial    disorders    consumables    mental    dna    material    shortcomings    site    generation    proprietary    strive    market    free    qualify    molecule    over    genetics    2018    constituting    biology    aggregated    molecules    bigger    cancer    globe    overcome    resolution    preparation    millions    round    minute    amount    diseases    musd    biopsies    reaction    sales    personalized    barriers    complexity   

Project "IMPACT" data sheet

The following table provides information about the project.

Coordinator
SAMPLIX ApS 

Organization address
address: MILEPARKEN 28
city: HERLEV
postcode: 2730
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 2˙669˙623 €
 EC max contribution 1˙868˙736 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAMPLIX ApS DK (HERLEV) coordinator 1˙868˙736.00

Map

 Project objective

Over the past 10 years DNA sequencing has revolutionized how we apply genetics in personalized healthcare, diagnosis and drug development despite that the sequencing technology comes with numerous shortcomings. Samplix has developed a proprietary technology, Xdrop™, which addresses these shortcomings. Samplix’ technology encompasses state of the art microfluidics, molecular biology and bioinformatics. The Xdrop technology enables scientists and medical personnel to retrieve specific single DNA molecules from a minute amount of biological sample e.g. tumour biopsies, for subsequent DNA sequencing. At the core of the Xdrop technology is the generation of millions of droplets, each droplet constituting a reaction chamber for the sample preparation of single DNA molecules. This is opposed to today’s technology which is based on bulk preparation of sample material for DNA sequencing. Single molecule resolution is key to understanding the complexity of major diseases such as cancer, immunological diseases, mental disorders, etc. The proposed project addresses the need to qualify known market barriers and put measures in place to overcome such market barriers. Samplix has engaged a very experienced management team with an aggregated experience of >50 years in developing and selling products for DNA analysis. Samplix has already established: • 5 test site agreements with leading DNA institutions around the globe • Agreements with leading OEM providers on instrument and consumables • A patent estate of 5 patent families. • Freedom to operate in multibillion € market. At Samplix, we strive at 100 mUSD in revenue and profitability in year five after full commercial launch. To achieve such an ambitious goal, we plan to apply a razor/razor blade sales strategy by installing the instrument “for free” in return for a subscription to consumables Samplix raised 4,5 m€ in May 2018 which brings the total capital raised to 8 m€. A bigger financing round is planned for 2019.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPACT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMPACT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More